POLA ORBIS HOLDINGS INC.
4927・Prime Market・Chemicals
Business
POLA ORBIS Holdings Inc. traces its origins to POLA, founded in 1929, and transitioned to a holding company structure in 2006. It is a cosmetics group that employs a multi-brand strategy, featuring POLA (prestige) and ORBIS (low- to mid-priced mail order) as core brands, alongside a diverse portfolio including Jurlique (natural, Australia), DECENCIA (sensitive skin), THREE (organic), and FUJIMI (personalized supplements). The group provides cosmetics, health foods, and beauty salon services both domestically and internationally, with consolidated net sales of ¥170,285 million for FY2025 (ending December 2025). The Beauty Care Business accounts for approximately 96% of sales, complemented by the Real Estate Business and Building Maintenance Business. Its main customers are beauty-conscious women both in Japan and overseas, reached through a variety of channels including door-to-door sales, directly-operated stores, e-commerce, and department stores.
Business Model
The POLA Brand is centered on consignment sales counseling by 17,498 Beauty Directors across 2,373 outlets nationwide, maintaining strong customer engagement through a commission structure linked to sales performance. ORBIS pursues customer retention and LTV improvement through a low-to-mid price range model combining mail-order sales, 93 directly-operated stores, and external channels. The group owns POLA Chemical Industries within its structure, establishing an integrated system from R&D to manufacturing. It differentiates itself through high-functionality skincare products leveraging approximately 22.1 million skin data records, securing stable revenue through repeat purchases.
Company Strengths
POLA Chemical Industries promotes R&D through a three-site structure comprising the Yokohama Research Institute, TDC, and NSG BioLabs Singapore. R&D expenses for FY2025 (ending December 2025) totaled ¥5,103 million. The company has a track record of developing proprietary ingredients such as the quasi-drug "Wrinkle Shot Medical Serum" and the whitening ingredient "Lucinol," earning high acclaim at domestic and international academic conferences including IFSCC.
The POLA Brand's core sales model is counseling-based sales by independently contracted Beauty Directors, with 2,373 stores and 17,498 sales partners nationwide as of the end of December 2025. The company also operates 407 "POLA THE BEAUTY" stores that combine esthetic treatments with cosmetics, achieving strong customer touchpoints and repeat purchasing.
As of the end of FY2025 (ending December 2025), the equity ratio stood at 82.3%, with extremely low interest-bearing debt and a cash flow to interest-bearing debt ratio of 0.1 years. Cash and deposits totaled a substantial ¥59,711 million. This near debt-free financial structure maintains the capacity for investment in R&D, M&A, and the cultivation of new brands.
ENVALITH's Perspective
Performance Trend
Revenue continued to languish after peaking at ¥178,642 million in 2021, falling to ¥170,285 million in 2025. The full-year forecast for 2026 calls for ¥173,000 million (up 1.6% year on year), suggesting a slight recovery. Meanwhile, operating profit improved from ¥13,810 million in 2024 to ¥15,693 million in 2025, and the full-year 2026 forecast of ¥17,300 million (up 10.2% year on year) points to a continuation of the profit improvement trend. In the first quarter of 2026, despite a slight decline in revenue, the operating margin improved from 10.0% to 12.1%. As external factors, changes in inbound consumption behavior (a decline in duty-free sales at department stores) and a gradual recovery in the Chinese market are affecting business performance.
Growth Strategy
Aiming to achieve mid-term management plan targets through three pillars: strengthening the domestic profit base, overseas growth, and profitability of growth brands
Accelerating the expansion of growth stores within the salon channel, improving profitability through the completion of the full renewal of "B.A," and streamlining the organization through the implementation of the voluntary early retirement program "Next Career Special Support Program." In China, efforts are underway to establish brand presence by expanding touchpoints with high-prestige customer segments and strengthening CRM.
Pursuing both an increase in purchase price through the proposal of high-function, high-priced products in the direct sales channel and the acquisition of new customers through expansion of external channels. Promoting stronger profit structure through building a customer base with high retention rates and LTV. In Q1 of 2026, the domestic business achieved year-on-year growth.
Through the expansion of brand recognition for DECENCIA (driven by a Best Cosmetics award for its new whitening series), growth in sales of THREE's Holistic Care line, and the growth of new businesses "Kaokara" and "Dive," the Growth Brands (DECENCIA, THREE, FUJIMI) as a whole achieved year-on-year sales growth. Operating losses are also on an improving trend.
In Australia, directly-operated stores, department stores, and e-commerce performed steadily, achieving year-on-year growth. In China, while department stores and cross-border e-commerce faced challenges, operating losses improved due to store closures and optimization of selling, general and administrative expenses. Consulting expenses of ¥451 million were recorded for business and organizational structure optimization, accelerating structural reform.
Last updated: July 17, 2026